Long QT Syndrome Screening in Newborns

Key facts

Sponsor

QT Medical, Inc.

Principal Investigator

Ruey-Kang Chang, M.D., M.P.H.

QT Medical, Inc.

Intervention

QTScreen ECG Recorder(device)

Enrollment

4000 enrolled

Eligibility

All sexes

Timeline

2015 – 2017

Study locations (3)

• St. Francis Medical Center, Lynwood, California, United States
• Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
• Providence Little Company of Mary Medical Center-Torrance, Torrance, California, United States

Collaborators

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · University of California, Irvine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Congenital long QT syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06887387
  Wearable Devices for Patient Monitoring in Long QT Syndrome
  Queen Mary University of London
• ENROLLING BY INVITATIONNANCT07233421
  Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome
  Helsinki University Central Hospital
• RECRUITINGNANCT04336644
  Continuous Versus Intermittent cARdiac Electrical moNitorinG
  Washington University School of Medicine
• RECRUITINGNANCT05348564
  Comparing Direct vs Indirect Methods for Cascade Screening
  University of Maryland, Baltimore
• RECRUITINGNCT06087367
  Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects
  Nantes University Hospital

See all trials for Congenital long QT syndrome →